Sonoma Pharmaceuticals Stock Price. Everything You Need To Know About The Sonoma Pharmaceuticals Stock!
Sonoma Pharmaceuticals, Inc. is a leading developer and producer of Stabilized Hypochlorous acid (HOCl) products with a broad range of applications, such as wound care, animal health care, eye care, nasal care, oral care, and dermatological conditions. The company’s headquarters are located in Boulder, Colorado and it currently has 12 full-time employees. Sonoma Pharmaceuticals went public on 2007-01-26 and has been offering innovative product offerings since then.
The firm’s portfolio includes a variety of products, such as Acuicyn, Endocyn, OroGenix Oral Hygiene Rinse, Microdacyn60 Oral Care, Sinudox, MicrocynAH, Nanocyn Disinfectant & Sanitizer, Epicyn Antimicrobial Facial Cleanser, Levicyn Antimicrobial Dermal Spray, Levicyn Antipruritic Gel, Levicyn Antipruritic Spray Gel, Celacyn Scar Management Gel, and Sebuderm Topical Gel. For instance, Acuicyn is a prescription solution designed to treat blepharitis and maintain eyelid and lash hygiene, reducing symptoms of redness, itchiness, crustiness, and inflammation. MicrocynAH is a HOCl-based topical product that cleans, debrides, and treats a range of animal wounds and infections. Celacyn is an excellent solution for scar management, providing protection and moisturization to wound and scar sites.
Being up to date with Sonoma Pharmaceuticals’ stock is vital for those interested in the industry, and it’s worth keeping an eye on their premarket and stock price today, as these can be indicators of performance. Researching Sonoma Pharmaceuticals and other stocks share price today, market cap, and news is crucial for investors looking to diversify their portfolio and make informed decisions.
Sonoma Pharmaceuticals Stock Price. Everything You Need To Know About The Sonoma Pharmaceuticals Stock! performance
- Employees 12
- Company HQ Boulder
- Website https://sonomapharma.com/
- SNOA Asset Type Common Stock
- SNOA Market Capitalization 2.5M
- Earnings Per Share -0.82
- Dividends Per Share None
- Dividend Date 2019-06-20
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further – Zorion has got you covered. With our investment platform, you can easily invest in real US stocks and Pre-IPO companies, including Sonoma Pharmaceuticals. Sonoma Pharmaceuticals is a renowned company in the healthcare industry, specializing in advanced wound care and dermatology solutions. If you’re interested in investing in this stock, Zorion provides valuable investment insights and recommendations to help you make informed decisions. Not only that, but you can also enhance your investment knowledge through our wide range of educational resources and materials. Start investing in Sonoma Pharmaceuticals today and watch your portfolio grow.
